Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;86:692-699

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yue, T.-L.
Right arrow Articles by Ohlstein, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yue, T.-L.
Right arrow Articles by Ohlstein, E. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Apoptosis
Right arrow Ischemic biology - basic studies
(Circulation Research. 2000;86:692.)
© 2000 American Heart Association, Inc.


Integrative Physiology

Inhibition of Extracellular Signal–Regulated Kinase Enhances Ischemia/Reoxygenation–Induced Apoptosis in Cultured Cardiac Myocytes and Exaggerates Reperfusion Injury in Isolated Perfused Heart

Presented in part at the 72nd Scientific Sessions of the American Heart Association, Atlanta, Ga, November 7–10, 1999, and published in abstract form (Circulation. 1999;100[suppl I]:I-63).

Tian-Li Yue, Chuanlin Wang, Juan-Li Gu, Xin-Ling Ma, Sanjay Kumar, John C. Lee, Giora Z. Feuerstein, Heath Thomas, Beverly Maleeff, Eliot H. Ohlstein

From the Departments of Cardiovascular Pharmacology (T-L.Y., C.W., J-L.G., G.Z F., E.H.O.), Bone and Cartilage (S.K., J.C.L.), and Experimental Toxicology (H.T., B.M.), SmithKline Beecham Pharmaceuticals, King of Prussia, and Division of Emergency Medicine (X-L.M.), Thomas Jefferson University, Philadelphia, Pa.

Correspondence to Tian-Li Yue, Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, 709 Swedeland Rd, PO Box 1539, UW 2510, King of Prussia, PA 19406. E-mail tian-li_yue{at}sbphrd.com

Abstract—Three major mammalian mitogen-activated protein kinases, extracellular signal–regulated kinase (ERK), p38, and c-Jun NH2-terminal protein kinase (JNK), have been identified in the cardiomyocyte, but their respective roles in the heart are not well understood. The present study explored their functions and cross talk in ischemia/reoxygenation (I/R)–induced cardiac apoptosis. Exposing rat neonatal cardiomyocytes to ischemia resulted in a rapid and transient activation of ERK, p38, and JNK. On reoxygenation, further activation of all 3 mitogen-activated protein kinases was noted; peak activities increased (fold) by 5.5, 5.2, and 6.2, respectively. Visual inspection of myocytes exposed to I/R identified 18.6% of the cells as showing morphological features of apoptosis, which was further confirmed by DNA ladder and terminal deoxyribonucleotide transferase–mediated dUTP nick end labeling (TUNEL). Myocytes treated with PD98059, a MAPK/ERK kinase (MEK1/MEK2) inhibitor, displayed a suppression of I/R-induced ERK activation, whereas p38 and JNK activities were increased by 70.3% and 55.0%, respectively. In addition, the number of apoptotic cells was increased to 33.4%. With pretreatment of cells with SB242719, a selective p38 inhibitor, or SB203580, a p38 and JNK2 inhibitor, I/R+PD98059-induced apoptotic cells were reduced by 42.8% and 63.3%, respectively. Hearts isolated from rats treated with PD98059 and subjected to global ischemia (30 minutes)/reoxygenation (1 hour) showed a diminished functional recovery compared with the vehicle group. Coadministration of SB203580 attenuated the detrimental effects of PD98059 and significantly improved cardiac functional recovery. The data taken together suggest that ERK plays a protective role, whereas p38 and JNK mediate apoptosis in cardiomyocytes subjected to I/R, and the dynamic balance of their activities is critical in determining cardiomyocyte fate subsequent to reperfusional injury.


Key Words: cardiomyocyte • ischemic injury • apoptosis • mitogen-activated protein kinase




This article has been cited by other articles:


Home page
Toxicol PatholHome page
E. Golomb, A. Nyska, and H. Schwalb
Occult Cardiotoxicity--Toxic Effects on Cardiac Ischemic Tolerance
Toxicol Pathol, August 1, 2009; 37(5): 572 - 593.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Das, F. N. Salloum, L. Xi, Y. J. Rao, and R. C. Kukreja
ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1236 - H1243.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. C. Jin, K. J. Kim, Y. M. Kim, Y. M. Ha, H. J. Kim, U. J. Yun, K. H. Bae, Y. S. Kim, S. S. Kang, H. G. Seo, et al.
Anti-Apoptotic Effect of Magnolol in Myocardial Ischemia and Reperfusion Injury Requires Extracellular Signal-Regulated Kinase1/2 Pathways in Rat In Vivo
Experimental Biology and Medicine, October 1, 2008; 233(10): 1280 - 1288.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. N. Willette, W. Bao, S. Nerurkar, T.-l. Yue, C. P. Doe, G. Stankus, G. H. Turner, H. Ju, H. Thomas, C. E. Fishman, et al.
Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Oshima, N. Ouchi, K. Sato, Y. Izumiya, D. R. Pimentel, and K. Walsh
Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart
Circulation, June 17, 2008; 117(24): 3099 - 3108.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan
Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Roubille, S. Combes, J. Leal-Sanchez, C. Barrere;, F. Cransac, C. Sportouch-Dukhan, G. Gahide, I. Serre, E. Kupfer, S. Richard, et al.
Myocardial Expression of a Dominant-Negative Form of Daxx Decreases Infarct Size and Attenuates Apoptosis in an In Vivo Mouse Model of Ischemia/Reperfusion Injury
Circulation, December 4, 2007; 116(23): 2709 - 2717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Zhang, W. E. Lawson, V. V. Polosukhin, A. Pozzi, T. S. Blackwell, Y. Litingtung, and C. Chiang
Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in Mice
Am. J. Pathol., October 1, 2007; 171(4): 1113 - 1126.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Wang
Mitogen-Activated Protein Kinases in Heart Development and Diseases
Circulation, September 18, 2007; 116(12): 1413 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, S. Fukuoka, C. Iwai, J. Liu, V. K. Sharma, S.-S. Sheu, M. Fu, and C.-s. Liang
Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1636 - H1645.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Caretti, S. Morel, G. Milano, M. Fantacci, P. Bianciardi, R. Ronchi, G. Vassalli, L. K. von Segesser, and M. Samaja
Heart HIF-1{alpha} and MAP Kinases During Hypoxia: Are They Associated In Vivo?
Experimental Biology and Medicine, July 1, 2007; 232(7): 887 - 894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Milano, S. Morel, C. Bonny, M. Samaja, L. K. von Segesser, P. Nicod, and G. Vassalli
A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1828 - H1835.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Huang, C. D. Wright, C. L. Merkwan, N. L. Baye, Q. Liang, P. C. Simpson, and T. D. O'Connell
An {alpha}1A-Adrenergic-Extracellular Signal-Regulated Kinase Survival Signaling Pathway in Cardiac Myocytes
Circulation, February 13, 2007; 115(6): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Das, A. Smolenski, S. M. Lohmann, and R. C. Kukreja
Cyclic GMP-dependent Protein Kinase I{alpha} Attenuates Necrosis and Apoptosis Following Ischemia/Reoxygenation in Adult Cardiomyocyte
J. Biol. Chem., December 15, 2006; 281(50): 38644 - 38652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Fiedler, R. Feil, F. Hofmann, C. Willenbockel, H. Drexler, A. Smolenski, S. M. Lohmann, and K. C. Wollert
cGMP-dependent Protein Kinase Type I Inhibits TAB1-p38 Mitogen-activated Protein Kinase Apoptosis Signaling in Cardiac Myocytes
J. Biol. Chem., October 27, 2006; 281(43): 32831 - 32840.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-J. Xu, H. K. Saini, M. Zhang, V. Elimban, and N. S. Dhalla
MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine
Cardiovasc Res, October 1, 2006; 72(1): 163 - 174.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. C. Weber, J. Stursberg, N. M. Wirthle, O. Toma, W. Schlack, and B. Preckel
Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo
Br. J. Anaesth., September 1, 2006; 97(3): 298 - 306.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. J. Crozier, X. Zhang, J. Wang, J. Cheung, S. R. Kimball, and L. S. Jefferson
Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion
J Appl Physiol, August 1, 2006; 101(2): 576 - 582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Toth, J. R. Jeffers, P. Nickson, J.-Y. Min, J. P. Morgan, G. P. Zambetti, and P. Erhardt
Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H52 - H60.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. K. Kutala, M. Khan, R. Mandal, L. P. Ganesan, S. Tridandapani, T. Kalai, K. Hideg, and P. Kuppusamy
Attenuation of Myocardial Ischemia-Reperfusion Injury by Trimetazidine Derivatives Functionalized with Antioxidant Properties
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 921 - 928.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Khan, S. Varadharaj, L. P. Ganesan, J. C. Shobha, M. U. Naidu, N. L. Parinandi, S. Tridandapani, V. K. Kutala, and P. Kuppusamy
C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2136 - H2145.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z.-Q. Zhao and J. Vinten-Johansen
Postconditioning: Reduction of reperfusion-induced injury
Cardiovasc Res, May 1, 2006; 70(2): 200 - 211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Lewthwaite, E. R. Bastow, K. J. Lamb, J. Blenis, C. P. D. Wheeler-Jones, and A. A. Pitsillides
A Specific Mechanomodulatory Role for p38 MAPK in Embryonic Joint Articular Surface Cell MEK-ERK Pathway Regulation
J. Biol. Chem., April 21, 2006; 281(16): 11011 - 11018.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Akhter, K. M. D'Souza, N. N. Petrashevskaya, J. Mialet-Perez, and S. B. Liggett
Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1427 - H1432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Toth, P. Nickson, L. L. Qin, and P. Erhardt
Differential Regulation of Cardiomyocyte Survival and Hypertrophy by MDM2, an E3 Ubiquitin Ligase
J. Biol. Chem., February 10, 2006; 281(6): 3679 - 3689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Palomeque, L. Sapia, R. J. Hajjar, A. Mattiazzi, and M. Vila Petroff
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H96 - H106.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Hashiguchi, H. Morooka, H. Miyoshi, M. Matsumoto, T. Koji, and K. Sumikawa
Isoflurane Protects Renal Function Against Ischemia and Reperfusion Through Inhibition of Protein Kinases, JNK and ERK
Anesth. Analg., December 1, 2005; 101(6): 1584 - 1589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. House, K. Branch, G. Newman, T. Doetschman, and J. E. J. Schultz
Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2167 - H2175.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
L. Button, S. E Mireylees, R. Germack, and J. M Dickenson
Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips
Exp Physiol, September 1, 2005; 90(5): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig
Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation
J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Bae, R. D. Gilbert, C. A. Ducsay, and L. Zhang
Prenatal cocaine exposure increases heart susceptibility to ischaemia-reperfusion injury in adult male but not female rats
J. Physiol., May 15, 2005; 565(1): 149 - 158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Reid, G. Kristo, Y. Yoshimura, C. Ballard-Croft, B. J. Keith, R. M. Mentzer Jr, and R. D. Lasley
In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2253 - H2259.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Kan, D. Birkle, A. C. Jain, C. Failinger, S. Xie, and M. S. Finkel
p38 MAP kinase inhibitor reverses stress-induced cardiac myocyte dysfunction
J Appl Physiol, January 1, 2005; 98(1): 77 - 82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Schulz
A new paradigm: cross talk of protein kinases during reperfusion saves life!
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H1 - H2.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Li, Y. Xiao, and L. Zhang
Cocaine Induces Apoptosis in Fetal Rat Myocardial Cells through the p38 Mitogen-Activated Protein Kinase and Mitochondrial/Cytochrome c Pathways
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
P. van der Meer, E. Lipsic, R. H. Henning, R. A. de Boer, A. J.H. Suurmeijer, D. J. van Veldhuisen, and W. H. van Gilst
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury
Eur J Heart Fail, December 1, 2004; 6(7): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. S. Brookes, Y. Yoon, J. L. Robotham, M. W. Anders, and S.-S. Sheu
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C817 - C833.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J Hausenloy, M. M Mocanu, and D. M Yellon
Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning
Cardiovasc Res, August 1, 2004; 63(2): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Liu and P. A. Hofmann
Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2204 - H2212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-Y. Xiao, K.-i. Yuhki, A. Hara, T. Fujino, S. Kuriyama, T. Yamada, K. Takayama, O. Takahata, H. Karibe, T. Taniguchi, et al.
Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4
Circulation, May 25, 2004; 109(20): 2462 - 2468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Li, S. Bae, and L. Zhang
Effect of prenatal hypoxia on heat stress-mediated cardioprotection in adult rat heart
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1712 - H1719.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Lips, O. F. Bueno, B. J. Wilkins, N. H. Purcell, R. A. Kaiser, J. N. Lorenz, L. Voisin, M. K. Saba-El-Leil, S. Meloche, J. Pouyssegur, et al.
MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo
Circulation, April 27, 2004; 109(16): 1938 - 1941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Xu, X. Ji, and P. G. Boysen
Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1433 - H1440.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. A. Khan, C. Bianchi, M. Ruel, P. Voisine, and F. W. Sellke
Mitogen-activated protein kinase pathways and cardiac surgery
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Liu, C. C. Chua, J. Gao, Z. Chen, C. L. C. Landy, R. Hamdy, and B. H. L. Chua
Pifithrin-{alpha} protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H933 - H939.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ishii, Y. Suzuki, K. Takeshita, N. Miyao, H. Kudo, R. Hiraoka, K. Nishio, N. Sato, K. Naoki, T. Aoki, et al.
Inhibition of c-Jun NH2-Terminal Kinase Activity Improves Ischemia/Reperfusion Injury in Rat Lungs
J. Immunol., February 15, 2004; 172(4): 2569 - 2577.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. C Armstrong
Protein kinase activation and myocardial ischemia/reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 427 - 436.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J Hausenloy and D. M Yellon
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
Cardiovasc Res, February 15, 2004; 61(3): 448 - 460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Kan, Z. Xie, and M. S. Finkel
p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes
Am J Physiol Cell Physiol, January 1, 2004; 286(1): C1 - C7.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. K. Brar, A. K. Jonassen, E. M. Egorina, A. Chen, A. Negro, M. H. Perrin, O. D. Mjos, D. S. Latchman, K.-F. Lee, and W. Vale
Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine Heart
Endocrinology, January 1, 2004; 145(1): 24 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Yaglom, D. Ekhterae, V. L. Gabai, and M. Y. Sherman
Regulation of Necrosis of H9c2 Myogenic Cells upon Transient Energy Deprivation: RAPID DEENERGIZATION OF MITOCHONDRIA PRECEDES NECROSIS AND IS CONTROLLED BY REACTIVE OXYGEN SPECIES, STRESS KINASE JNK, HSP72, AND ARC
J. Biol. Chem., December 12, 2003; 278(50): 50483 - 50496.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. Kumar, V. Menon, W. R. Ford, A. S. Clanachan, and B. I. Jugdutt
Effect of Angiotensin II lype 2 Receptor Blockade on Activation of Mitogen-Activated Protein Kinases after Ischemia-Reperfusion in Isolated Working Rat Hearts
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 285 - 296.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. Tanno, R. Bassi, D. A. Gorog, A. T. Saurin, J. Jiang, R. J. Heads, J. L. Martin, R. J. Davis, R. A. Flavell, and M. S. Marber
Diverse Mechanisms of Myocardial p38 Mitogen-Activated Protein Kinase Activation: Evidence for MKK-Independent Activation by a TAB1-Associated Mechanism Contributing to Injury During Myocardial Ischemia
Circ. Res., August 8, 2003; 93(3): 254 - 261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Maejima, S. Adachi, H. Ito, K. Nobori, M. Tamamori-Adachi, and M. Isobe
Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity
Cardiovasc Res, August 1, 2003; 59(2): 308 - 320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Qin, J. Shite, and C.-s. Liang
Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang
Effect of Fetal Hypoxia on Heart Susceptibility to Ischemia and Reperfusion Injury in the Adult Rat
Reproductive Sciences, July 1, 2003; 10(5): 265 - 274.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
R. Song, M. Kubo, D. Morse, Z. Zhou, X. Zhang, J. H. Dauber, J. Fabisiak, S. M. Alber, S. C. Watkins, B. S. Zuckerbraun, et al.
Carbon Monoxide Induces Cytoprotection in Rat Orthotopic Lung Transplantation via Anti-Inflammatory and Anti-Apoptotic Effects
Am. J. Pathol., July 1, 2003; 163(1): 231 - 242.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
O. F. Bueno and J. D. Molkentin
Involvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death
Circ. Res., November 1, 2002; 91(9): 776 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P A J Krijnen, R Nijmeijer, C J L M Meijer, C A Visser, C E Hack, and H W M Niessen
Apoptosis in myocardial ischaemia and infarction
J. Clin. Pathol., November 1, 2002; 55(11): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Schulman, D. S. Latchman, and D. M. Yellon
Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1481 - H1488.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Ogita, K. Node, H. Asanuma, S. Sanada, Y. Liao, S. Takashima, M. Asakura, H. Mori, Y. Shinozaki, M. Hori, et al.
Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Yue, Q. Qin, M. V Cohen, J. M Downey, and S. D Critz
The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart
Cardiovasc Res, August 15, 2002; 55(3): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. S. Frey, A. Rahman, J. C. Kefer, R. D. Minshall, and A. B. Malik
PKC{zeta} Regulates TNF-{alpha}-Induced Activation of NADPH Oxidase in Endothelial Cells
Circ. Res., May 17, 2002; 90(9): 1012 - 1019.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Jiang, Y. Jia, and I. Cohen
Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation
Blood, May 15, 2002; 99(10): 3579 - 3584.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Luo, B. Yanagawa, J. Zhang, Z. Luo, M. Zhang, M. Esfandiarei, C. Carthy, J. E. Wilson, D. Yang, and B. M. McManus
Coxsackievirus B3 Replication Is Reduced by Inhibition of the Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway
J. Virol., March 7, 2002; 76(7): 3365 - 3373.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Liao, S.-Q. Wang, S. Wang, M. Zheng, M. Zheng, S.-J. Zhang, H. Cheng, Y. Wang, and R.-P. Xiao
p38 Mitogen-Activated Protein Kinase Mediates a Negative Inotropic Effect in Cardiac Myocytes
Circ. Res., February 8, 2002; 90(2): 190 - 196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. M. Becker, A. D. Verin, M. A. Booth, F. Liu, A. Birukova, and J. G. N. Garcia
Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1500 - L1511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Wei, E. C. Rothstein, L. Fliegel, L. J. Dell'Italia, and P. A. Lucchesi
Differential MAP kinase activation and Na+/H+ exchanger phosphorylation by H2O2 in rat cardiac myocytes
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1542 - C1550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Okamoto, A. Chaves, J. Chen, R. Kelley, K. Jones, H. G. Weed, K. L. Gardner, L. Gangi, M. Yamaguchi, W. Klomkleaw, et al.
Transgenic Mice with Cardiac-Specific Expression of Activating Transcription Factor 3, a Stress-Inducible Gene, Have Conduction Abnormalities and Contractile Dysfunction
Am. J. Pathol., August 1, 2001; 159(2): 639 - 650.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
H. Ueda, T. Nakamura, K. Matsumoto, Y. Sawa, H. Matsuda, and T. Nakamura
A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats
Cardiovasc Res, July 1, 2001; 51(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross
Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. G. Araujo, C. Bianchi, K. Sato, R. Faro, X. A. Li, and F. W. Sellke
Inactivation of the MEK/ERK pathway in the myocardium during cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. H. Wang
Roads to Survival : Insulin-Like Growth Factor-1 Signaling Pathways in Cardiac Muscle
Circ. Res., March 30, 2001; 88(6): 552 - 554.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yamashita, J. Kajstura, D. J. Discher, B. J. Wasserlauf, N. H. Bishopric, P. Anversa, and K. A. Webster
Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-1
Circ. Res., March 30, 2001; 88(6): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. T. SAURIN, J. L. MARTIN, R. J. HEADS, C. FOLEY, J. W. MOCKRIDGE, M. J. WRIGHT, Y. WANG, and M. S. MARBER
The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes
FASEB J, November 1, 2000; 14(14): 2237 - 2246.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Thibonnier, D. M. Conarty, and C. L. Plesnicher
Mediators of the mitogenic action of human V1 vascular vasopressin receptors
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2529 - H2539.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-i. Abe, C. P. Baines, and B. C. Berk
Role of Mitogen-Activated Protein Kinases in Ischemia and Reperfusion Injury : The Good and the Bad
Circ. Res., March 31, 2000; 86(6): 607 - 609.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. L. Gabai, A. B. Meriin, J. A. Yaglom, J. Y. Wei, D. D. Mosser, and M. Y. Sherman
Suppression of Stress Kinase JNK Is Involved in HSP72-mediated Protection of Myogenic Cells from Transient Energy Deprivation. HSP72 ALLEVIATES THE STRESS-INDUCED INHIBITION OF JNK DEPHOSPHORYLATION
J. Biol. Chem., November 22, 2000; 275(48): 38088 - 38094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-L. Yue, J.-L. Gu, C. Wang, A. D. Reith, J. C. Lee, R. C. Mirabile, R. Kreutz, Y. Wang, B. Maleeff, A. A. Parsons, et al.
Extracellular Signal-regulated Kinase Plays an Essential Role in Hypertrophic Agonists, Endothelin-1 and Phenylephrine-induced Cardiomyocyte Hypertrophy
J. Biol. Chem., November 22, 2000; 275(48): 37895 - 37901.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Liao, S.-Q. Wang, S. Wang, M. Zheng, M. Zheng, S.-J. Zhang, H. Cheng, Y. Wang, and R.-P. Xiao
p38 Mitogen-Activated Protein Kinase Mediates a Negative Inotropic Effect in Cardiac Myocytes
Circ. Res., February 8, 2002; 90(2): 190 - 196.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Patel, Q.-J. Zhang, K. Siddle, M. A. Soos, M. Goddard, P. L. Weissberg, and M. R. Bennett
Defect in Insulin-Like Growth Factor-1 Survival Mechanism in Atherosclerotic Plaque-Derived Vascular Smooth Muscle Cells Is Mediated by Reduced Surface Binding and Signaling
Circ. Res., May 11, 2001; 88(9): 895 - 902.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Gao, E. Gao, T.-L. Yue, E. H. Ohlstein, B. L. Lopez, T. A. Christopher, and X.-L. Ma
Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-Reperfusion: The Roles of PI3-Kinase, Akt, and Endothelial Nitric Oxide Synthase Phosphorylation
Circulation, March 26, 2002; 105(12): 1497 - 1502.
[Abstract] [Full Text] [PDF]